| 1 |
35412302 | Iodine Conjugated Pt(IV) Nanoparticles for Precise Chemotherapy with Iodine-Pt Guided Computed Tomography Imaging and Biotin-Mediated Tumor-Targeting. | 2022 Apr 12 |
1 |
| 2 |
33153817 | Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment. | 2021 Jun |
2 |
| 3 |
33744756 | Oxidative stress cytotoxicity induced by platinum-doped magnesia nanoparticles in cancer cells. | 2021 Jun |
1 |
| 4 |
34293698 | Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. | 2021 Nov 15 |
1 |
| 5 |
34365218 | Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. | 2021 Nov |
2 |
| 6 |
34583845 | Re: Vicenç Ruiz de Porras, Xieng C. Wang, Luis Palomero, et al. Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment. Eur Urol 2021;79:722-33. | 2021 Dec |
1 |
| 7 |
34794242 | The endocytic pathway of Pt nanoclusters and their induced apoptosis of A549 and A549/Cis cells through c-Myc/p53 and Bcl-2/caspase-3 signaling pathways. | 2021 Dec |
1 |
| 8 |
32309901 | Platinum nanoparticles induced genotoxicity and apoptotic activity in human normal and cancer hepatic cells via oxidative stress-mediated Bax/Bcl-2 and caspase-3 expression. | 2020 Sep |
1 |
| 9 |
32703189 | A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway. | 2020 Jul 23 |
1 |
| 10 |
30774376 | Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2. | 2019 |
1 |
| 11 |
28166401 | Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents. | 2017 Mar 1 |
4 |
| 12 |
26893680 | Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer. | 2016 Feb |
1 |
| 13 |
27062783 | [Expression of MiR-130a in Serum Samples of Patients with Epithelial Ovarian Cancer and Its Association with Platinum Resistance]. | 2016 Jan |
2 |
| 14 |
27822420 | Genetic variants of BCL2 gene predict clinical outcomes of non-small-cell lung cancer patients treated with platinum-based chemotherapy in a Chinese population. | 2016 |
5 |
| 15 |
26656462 | Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy. | 2015 Dec 10 |
2 |
| 16 |
24560445 | Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts. | 2014 May |
1 |
| 17 |
23455184 | Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer. | 2013 Dec |
1 |
| 18 |
19240170 | Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. | 2009 Mar 1 |
2 |
| 19 |
19516889 | The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells. | 2009 |
1 |
| 20 |
17160181 | Synthesis and reactivity of dichloroboryl complexes of platinum(II). | 2007 Jan 7 |
1 |
| 21 |
15072449 | Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. | 2004 Mar-Apr |
1 |
| 22 |
12644821 | Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. | 2003 Mar 24 |
1 |
| 23 |
10807947 | Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs. | 2000 Jul 1 |
1 |
| 24 |
9891541 | p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. | 1998 Nov-Dec |
1 |